Promising new cholesterol-lowering drugs, priced at $14,000 a year per person, could add $120 billion annually to the USA's health care costs if taken by all eligible patients, according to an economic analysis published Tuesday in JAMA.
Authors of the analysis said they hope the estimate will spur a national conversation about drug prices, the value of new medications and how much Americans are willing to pay to improve health.
Read Full Article »